Critical pathways to success in CNS drug development /
General Material Designation
[Book]
First Statement of Responsibility
Neal R. Cutler ... [et al.]
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Hoboken, NJ :
Name of Publisher, Distributor, etc.
Wiley-Blackwell,
Date of Publication, Distribution, etc.
2010
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
viii, 263 p. :
Other Physical Details
ill. ;
Dimensions
24 cm
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
The impending crisis in CNS drug development -- Animal models and procedures for CNS disorders -- Preclinical antecedents to early human clinical trials -- Biomarkers and surrogate markers in drug development -- Neuroimaging and cognitive assessments in early drug development -- Bridging and CSF studies -- A case study from preclinical to early clinical trials
0
TOPICAL NAME USED AS SUBJECT
Central nervous system-- Effect of drugs on-- Research-- Methodology